Editorial on Multimodal Analgesia
Anaesthesia and Critical Care Medicine Journal · 20.05.2026 · 11 (1) · 1-2
DOI: 10.23880/accmj-16000255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anaesthesia and Critical Care Medicine Journal, online erschienen am 20.05.2026. Verfasst von Chouhan SN und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Multimodal therapy or Multimodal analgesia is widely used in the operating room to decrease opioid related adverse effects postoperatively. Many may use it, but not all, multimodal analgesia should become a standard of care because of the synergistic and opioid sparing effects. Multimodal therapy is comprised of, but not limited to, administering agents such as Acetaminophen, NSAIDs, Ketamine, and Dexmedetomidine, along with Ondansetron, Magnesium, and Dexamethasone, for the management of postoperative nausea, vomiting, and pain. Not only does it benefit our patients, but it also reduces hospital length of stay, enhances recovery time, improves patient satisfaction, and lowers complication rates.
Zitieren
APA
SN, C., & Y, M. (2026). Editorial on Multimodal Analgesia. Anaesthesia and Critical Care Medicine Journal, 11(1), 1-2. https://doi.org/10.23880/accmj-16000255
Vancouver
SN C, Y M. Editorial on Multimodal Analgesia. Anaesthesia and Critical Care Medicine Journal. 2026;11(1):1-2. doi:10.23880/accmj-16000255
BibTeX
@article{SN2026,
author = {SN, Chouhan and Y, Mcfarlane},
title = {Editorial on Multimodal Analgesia},
journal = {Anaesthesia and Critical Care Medicine Journal},
year = {2026},
volume = {11},
number = {1},
pages = {1--2},
doi = {10.23880/accmj-16000255}
}
EUVIMED